Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Health And Human Services was posted on October 19, 2021. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services

Closed
75N91021R00045Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911PT26SC001
The U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) has issued solicitation W911PT26SC001, a Commercial Solutions Opening (CSO) authorized under the National Defense Authorization Act for Fiscal Year 2026 and DFARS Subpart 212.70. This competitive solicitation is open until September 30, 2027, and is designed to acquire innovative commercial products, technologies, and services to modernize the Army's Organic Industrial Base. The scope focuses on integrating manufacturing resources, linking legacy analogue systems with digital systems, and expanding modeling and simulation to enhance the delivery of materiel solutions. The CSO targets both traditional and non-traditional business entities, including small businesses and foreign-owned firms, provided they maintain an active System for Award Management (SAM) profile and a Unique Entity ID. The acquisition process follows a multi-phased approach consisting of a written solution brief, an optional presentation or pitch, and a final Request for Commercial Solution Proposal (CSP). Evaluation is based on responsiveness, technical merit, uniqueness, and price reasonableness. Successful responses may result in fixed-price contracts awarded under FAR Part 12 Commercial Item Procedures. Current Areas of Interest (AoIs) include advanced cannon technology, electrical infrastructure improvements at Building 120, chromium facility conversion, automated manufacturing for minor components, automated cooling tower treatments, advanced CNC vertical turning lathes, and advanced tooling for radial forging. Performance is primarily located at Watervliet Arsenal and Benet Laboratories, with a general period of performance not to exceed 12 months unless otherwise specified.
W6QK Acc Wva

POSTED

about 16 hours ago

DEADLINE

in 11 months
NAICS: 541715
New
Grant
Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
Solicitation # RFA-DC-28-002
Solicitation RFA-DC-28-002 is a Notice of Funding Opportunity from the National Institutes of Health, specifically the National Institute on Deafness and Other Communication Disorders, to establish a Coordinating Center for the NIDCD National Human Ear Resource Network. This collaborative network provides human inner and middle ear tissues to researchers for basic and clinical studies aimed at advancing the treatment of auditory and vestibular disorders. The Coordinating Center is responsible for maintaining network cohesiveness through the planning of workshops, symposia, and regular meetings, providing updates to laboratories, and managing communication with the public and scientific community regarding tissue donation. The maximum project period is five years, with a budget limit of 200,000 dollars in direct costs per year. Applicants, including for-profit organizations and small businesses, must maintain active registrations in SAM, eRA Commons, and Grants.gov. Proposals are evaluated based on the significance of the proposed center and the qualifications of the investigators, with additional reviews for human subject protections, inclusion policies, and the use of vertebrate animals. Key requirements include a structured Data Management and Sharing Plan and adherence to cybersecurity guidelines, including a 48-hour incident reporting window. The application process is entirely electronic and requires several standard PHS and SF424 forms, with a response deadline of March 5, 2027.
National Institutes Of Health

POSTED

about 24 hours ago

DEADLINE

in 5 months
NAICS: 541715
New
Grant
National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
Solicitation # RFA-DC-28-001
Solicitation RFA-DC-28-001 is a Notice of Funding Opportunity issued by the National Institutes of Health under the Department of Health and Human Services to support the NIDCD National Human Ear Resource Network. The objective is to maintain a collaborative network of laboratories that serve as a national technological resource, providing human inner and middle ear tissues to researchers for basic and clinical studies to advance the treatment of auditory and vestibular disorders. The scope of work includes processing human temporal bones from the National Hearing and Balance Organ Donor Program, uploading images and medical data to EarBase, sharing gene-expression data via the gEAR repository, and providing technical instruction to increase the number of skilled researchers in the field. The NIDCD intends to commit 3.6 million dollars in FY 2028 to fund up to six awards, with a maximum project period of five years. Individual awards are limited to 450,000 dollars in direct costs per year, with an additional 150,000 dollars available for specific subawards. Applications are due on March 05, 2027, and November 01, 2027, with staggered start dates ranging from July 2027 to July 2028. Evaluation is based on the experience of the investigators, the adequacy of the institutional environment, and the protection of human subjects. Applicants must maintain active SAM registration and a Unique Entity Identifier, and they must provide a Data Management and Sharing Plan and a Material Transfer Agreement. Compliance with the Cybersecurity Act of 2015 is required, including the development of an incident response plan and notification of cybersecurity incidents within 48 hours of discovery.
National Institutes Of Health

POSTED

about 24 hours ago

DEADLINE

in about 1 year

General Info

Contract Value

$109

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Rockville, MD, 20852, USA

Set-Aside

NONE

Award Issued Date

Documents

3

75N91021R00045+Amendment+2+10.19.2021_.pdf

PDF

SF30+Amendment+1.pdf

PDF

Solicitation+10.04.2021+with+attachments.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

2 updates
PhaseClosed
Posted

Solicitation

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → NIH Nci
Contacts2 people available
OfficeBethesda, MD, 20892, USA
Office AddressBethesda, MD, 20892, USA

Full Description

Show more
** See Amendment 2 - The purpose of this amendment is to: 1) Provide responses to questions received; 2) revise Section M, Att 4, 11 and 15; and 3) revise Section I.4 to include FAR 52.223-99. ** See Amendment 1 - The purpose of this amendment is to clarify the due date for questions is Friday October 15, 2021. The Division of Cancer Epidemiology and Genetics (DCEG), NCI conducts broad-based, high quality, high impact epidemiologic and genetic research to uncover the causes of cancer in order to facilitate prevention. DCEG maintains a national and international perspective, giving priority to emergent issues identified through epidemiologic, clinical, and laboratory observations, as well as to public health concerns identified by the NCI, Congress, regulatory agencies and other appropriate bodies. The Division develops research resources and strategic partnerships in cancer epidemiology and genetics across NCI, NIH, and the global research community. DCEG has approximately 150 scientists whose activities could potentially be supported by this acquisition. Previously services were solicited individually to support each branch. This acquisition will be division wide. Purpose and Objectives: The goal of this acquisition is to support field preparation, biospecimen collection, and clinical activities in support of, but not limited to, the ongoing epidemiology and genetic research programs, conducted in the Branches and Laboratories in DCEG which include large scale domestic and international studies with diverse study designs in epidemiology and genetics research including retrospective and cohort studies, case-control studies, family studies, and randomized clinical trials. These studies span several geographic areas (potentially in any continent), are of varying size and complexity, and include dense, high-dimensional data on exposures, endpoints, clinical information, and biomarkers from molecular technologies. The contractor(s) shall furnish all the necessary services, qualified personnel, material, equipment, and facilities, not otherwise provided by the Government as needed to perform the work as defined in the Statement of Work. The contractor(s) shall coordinate and integrate all activities including staffing decisions, prioritizing support for projects, and managing and monitoring any subcontracts and consultants for task orders which will includes one or more of the task areas below and as defined in the Statement of Work. Offerors must propose services under Task Area A and under any one or more from task areas B through E. Project Requirements: Task Area A: Contract Transition-In/Out Transition In: Where applicable, the Contractor shall work with previous support service contractor(s) to ensure orderly transition of all contract activities and materials to establish the necessary integrated infrastructure and procedures for effective communication between the contractor and the Government for the period of the contract. Activities performed by the Contractor may include, but are not limited to participating at a kick-off meeting; providing a summary of capabilities to the Contracting Officers Representative (COR), establishing a consistent method of reporting that tracks labor hours for individual studies/project identifiers; establishing a method for data and knowledge transfer from incumbent Contractor, as required. Transition Out: Prior to expiration of a task order, the Contractor shall work with the Government and any successor Contractor(s) to carry out transition activities. The Contractor shall ensure the orderly, efficient, and safe transition of all contract activities and materials. Task Area B: Field Preparation, Study Management, and Support Activities The Contractor shall perform all activities necessary to prepare for, and implement, participant recruitment, follow-up, and biospecimen and data collections for domestic and international field studies. Activities performed by the Contractor include but are not limited to: establishing procedures and providing support activities for collecting, processing, analyzing, shipping, and storing data, biospecimens, and environmental and other samples. The Contractor shall assist NCI with the preparation of study materials (e.g., procedures manuals, training materials, data collection forms, questionnaires, coding manuals, data dictionaries, standard operating procedures, and study material translation for foreign studies); performing data linkages from various sources such as National Death Index for status and tumor registries for cancer status; reviewing and extracting data from medical records; managing data and research study record storage; providing computer programming, data processing, and data management for the collection and curation of field, biospecimen, and clinical study data; ensuring compliance with regulatory and administrative processes such as human subjects protection (e.g., obtain Institutional Review Board approval as required); and performing administrative, operational, and technical duties to support productive collaboration between the Government and any relevant third party contractor personnel. Task Area C: Biospecimen Activities and Assay Support The Contractor will cover three general areas: 1) the procurement, storage and shipment of specimen collection supplies to international and domestic specimen collection sites; 2) specimen processing, performance of state-of-the-art molecular assays (e.g., testing of samples from a repository or collected under Task Area B) and monitoring laboratory performance; and 3) preparing specimens for transport to testing laboratories by aliquoting, labeling and batching, as needed. Task Area D: Exposure Assessment The Contractor shall provide support to conduct specialized exposure assessment in the context of epidemiologic studies. Examples of exposure measurement collection include, but are not limited to, occupational, environmental, and behavioral exposure (e.g. sleep, light, physical activity, travel). This could involve on-site evaluation through real-time monitoring (e.g. air pollutants); remote collection, linkage, and synthesizing of existing environmental and personal monitoring data and application of personal monitoring systems via wearable or other mobile technologies. The Contractor shall support the collection, storage, shipment, and tracking of specialized exposure data and/or biospecimens (e.g., soil, archived tissues, milk, teeth, blood); compile and integrate newly collected and existing exposure measurements originally collected for regulatory or other external monitoring needs, or data derived through linkages to participants or geographic-based proxies (e.g., Geographic Information Systems (GIS)); and use research tools developed for exposure assessment evaluation (e.g., human-like phantoms, computerized treatment planning programs, Government-developed software, polysomnography, double labeled water). The Contractor shall manage and support exposure equipment testing as needed. Additionally, the Contractor shall support development of IT infrastructure for data storage, access, and application of state-of-the-art modeling of relevant exposure metrics. Task Area E: Clinical Support Activities The Contractor shall provide support for clinical studies. Activities performed by the Contractor include but are not limited to providing support for cancer risk assessment/genetic counseling; and scheduling travel plans and admission to the NIH Clinical Center for participating individuals and their family members. These skillsets and specialist support also may be required both domestically and internationally and/or for multiple studies of varying complexity.

More opportunities from Department Of Health And Human Services → NIH Nci

Same awarding agency

NAICS: 622110
Federal
NCI 2026 Cervical Cancer Screening Follow-Up
Solicitation # NCI-SBSS-DCEG-TDRP-0001
The National Cancer Institute (NCI) has issued a Small Business Sources Sought notice, NCI-SBSS-DCEG-TDRP-0001, to identify qualified small business sources for the 2026 Cervical Cancer Screening Follow-Up project. The primary objective is to obtain de-identified clinical and risk factor history and follow-up data for women previously enrolled in cervical cancer screening studies at Kaiser Permanente Northern California. This data, which includes HPV and cytology-based testing, colposcopy, biopsy, and treatment procedures, will be used to generate long-term risk estimates. The acquisition falls under NAICS code 622110 for General Medical and Surgical Hospitals, with a size standard of 47 million dollars. The anticipated period of performance is five years, spanning from January 25, 2027, to January 24, 2032, consisting of a 12-month base year and four 12-month option years. The selected contractor will be required to deliver five annual data sets in .txt, SAS, or EXCEL formats via NCI-approved secure encrypted methods, ensuring compliance with Section 508 ICT accessibility requirements. Additionally, the contractor must participate in quarterly WebEx meetings to review progress. Interested small businesses, including HUBZone, veteran-owned, 8(a), and woman-owned concerns, must submit a tailored capability statement of no more than five pages to the designated contracting officers by 8:00 AM Eastern Time on October 26, 2026.
General Medical and Surgical Hospitals

POSTED

13 days ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS